Clinical Trials on Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8 in Germany

Total 1 results

National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Lynch Syndrome | Stage III Colon Cancer AJCC v8 | Colon Adenocarcinoma | DNA Repair Disorder

United States, Puerto Rico, Germany

3

Subscribe